CVIE Among Ex-US Broad ETFs
End-of-day Nov 17, 2026 · 138 Ex-US broad ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.5% | −3.6% | −4.0% | −8.6% | +10.0% | +13.9% | +71.4% | — | — | +67.6% |
| Peer average | −1.6% | −3.2% | −3.0% | −6.8% | +6.5% | +9.5% | +62.4% | +43.4% | +130.0% | — |
| S&P 500 · VOO | −1.0% | −2.4% | −4.5% | −4.5% | +8.3% | +10.2% | +72.7% | +68.0% | +305.1% | — |
$54 of every $1,000 in CVIE is Taiwan
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | 2330.TWTaiwan Semiconductor | Technology | 5.42% | $541.75 | 397K | $26.7M |
| 2 | 005930.KSSamsung Electronics | Technology | 2.62% | $261.86 | 88K | $12.9M |
| 3 | ASML.ASAsml | Technology | 1.96% | $196.03 | 6,723 | $9.7M |
| 4 | 000660.KSSK Hynix | Technology | 1.70% | $170.04 | 9,994 | $8.4M |
| 5 | ROP.SWRoche AG | Healthcare | 1.30% | $130.36 | 13K | $6.4M |
| 6 | NOVN.SWNovartis AG | Healthcare | 1.11% | $110.79 | 34K | $5.5M |
| 7 | AZN.LAstrazeneca | Healthcare | 1.10% | $109.86 | 29K | $5.4M |
| 8 | HSBA.LHsbc | Financial Services | 1.08% | $107.98 | 300K | $5.3M |
| 9 | RY.TORoyal Bank OF Canada | Financial Services | 1.04% | $104.38 | 26K | $5.1M |
| 10 | NESN.SWNestle | Consumer Defensive | 1.02% | $102.10 | 48K | $5.0M |
| 11 | SAP.DESAP SE EUR 0 | Technology | 0.94% | $93.64 | 20K | $4.6M |
| 12 | SIE.DESiemens AG | Industrials | 0.90% | $90.08 | 15K | $4.4M |
| 13 | 8306.TMitsubishi UFJ Financial | Financial Services | 0.82% | $82.22 | 189K | $4.1M |
| 14 | TD.TOToronto-dominion Bank/the | Financial Services | 0.80% | $79.75 | 32K | $3.9M |
| 15 | ALV.DEAllianz SE | Financial Services | 0.74% | $74.18 | 6,995 | $3.7M |
of the $665B in 176 Ex-US broad ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | 2330.TW | Taiwan Semiconductor | 5.42% |
| 2 | 005930.KS | Samsung Electronics | 2.62% |
| 3 | ASML.AS | Asml | 1.96% |
| 4 | 000660.KS | SK Hynix | 1.70% |
| 5 | ROP.SW | Roche AG | 1.30% |
| 6 | NOVN.SW | Novartis AG | 1.11% |
| 7 | AZN.L | Astrazeneca | 1.10% |
| 8 | HSBA.L | Hsbc | 1.08% |
| 9 | RY.TO | Royal Bank OF Canada | 1.04% |
| 10 | NESN.SW | Nestle | 1.02% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 21, 2026 | Sep 25, 2026 | $0.25 |
| Jun 22, 2026 | Jun 26, 2026 | $0.77 |
| Mar 23, 2026 | Mar 27, 2026 | $0.0462 |
| Dec 23, 2025 | Dec 30, 2025 | $0.92 |
| Sep 22, 2025 | Sep 26, 2025 | $0.23 |
| Jun 23, 2025 | Jun 27, 2025 | $0.68 |
| Mar 24, 2025 | Mar 28, 2025 | $0.19 |
| Dec 23, 2024 | Dec 27, 2024 | $0.52 |
| Sep 23, 2024 | Sep 27, 2024 | $0.22 |
| Jun 24, 2024 | Jun 28, 2024 | $0.67 |
| Mar 18, 2024 | Mar 22, 2024 | $0.13 |
| Dec 18, 2023 | Dec 22, 2023 | $0.26 |